Vanderbilt-Ingram Cancer Center celebrated a ribbon cutting recently  at the Cookeville Regional Medical Center Cancer Center, where Vanderbilt-Ingram medical oncologists, radiation oncologists and advanced practice nurses are now the exclusive providers for cancer care.

There, she will develop and implement program aims, participate in strategic decision-making in the Cancer Center, direct pilot project funding, facilitate interactions among Cancer Center members, and assist in the recruiting activities for the 42-member program with over $11.7 million in annual peer-reviewed funding.

The findings were so promising that the clinical trial is being redesigned to investigate whether radiation treatment can also be avoided.

The authors hope the report will provide insight on the importance of education, screening and awareness to all health care providers.

The Vanderbilt study used RNA-sequencing data generated in multiple normal tissues, along with matched genotype data from the Genotype-Tissue Expression Project as well as large-scale genomic data for cancers of the breast, ovary, prostate, colorectum, lung and pancreas.

Through this agreement Vanderbilt-Ingram Cancer Center’s medical oncologists, radiation oncologists and advanced practice nurses will be Cookeville Regional’s exclusive providers of cancer services.

Speakers at the Vanderbilt-Ingram Cancer Center 25th Annual Scientific Retreat detailed the history of hereditary cancer discoveries and gave overviews about ongoing research.